Moderna
MRNA
#276
Rank
NZ$151.80 B
Marketcap
NZ$375.19
Share price
3.43%
Change (1 day)
771.16%
Change (1 year)
Moderna, Inc. is an American biotechnology company focused on the discovery and development of messenger RNA-based drugs.

EPS for Moderna (MRNA)

EPS in 2026 (TTM): NZ-$13.90

According to Moderna 's latest financial reports the company's current EPS (TTM) is NZ-$14.54. In 2025 the company made an earnings per share (EPS) of NZ-$13.23 an increase over its 2024 EPS that were of NZ-$16.89.

EPS history for Moderna from 2018 to 2026

Annual EPS

Year EPS Change
2026 (TTM)NZ-$13.905.07%
2025NZ-$13.23-21.66%
2024NZ-$16.89-25.04%
2023NZ-$22.53-158.62%
2022NZ$38.43-30.25%
2021NZ$55.10-1660.82%
2020NZ-$3.5325.32%
2019NZ-$2.8236.87%
2018NZ-$2.06

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Johnson & Johnson
JNJ
NZ$12.16-183.60%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
NZ$9.55-165.71%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Merck
MRK
NZ$1.81-112.43%๐Ÿ‡บ๐Ÿ‡ธ USA
Regulus Therapeutics
RGLS
NZ-$1.33-90.86%๐Ÿ‡บ๐Ÿ‡ธ USA
Athersys
ATHX
NZ-$3.69-74.59%๐Ÿ‡บ๐Ÿ‡ธ USA
Alnylam Pharmaceuticals
ALNY
NZ$36.05-347.93%๐Ÿ‡บ๐Ÿ‡ธ USA
Arrowhead Pharmaceuticals
ARWR
NZ-$6.06-58.32%๐Ÿ‡บ๐Ÿ‡ธ USA